MMR vaccine (Measles, Mumps, Rubella) Tdap-IPV vaccine (Tetanus, Diphteria, Pertussis, Polio) Infections and Infestations MMR vaccine (Measles, Mumps, Rubella) Tdap-IPV vaccine (Tetanus, Diphteria, Pertussis, Polio)
Conditions
Interventions
The Prevention Bus will be at each school for approximately one week. Giving all students the possibility to get information and/or vaccination if needed. Besides that, there is an intervention at the
Sponsors
Federal Ministery of Health (BMG)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: School level: 1. Centric boroughs within circle line ("Ringbahn" - public Transport Berlin) 2. Summed minimum number of pupils in potential School classes: 230 Participant level: 1. Age (>15 years) 2. Signed informed consent by the parents
Exclusion criteria
Exclusion criteria: Under 15 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaccination rate is objectively measured through the number of pupils that get vaccinated, directly after receiving treatment (educational class condition, low-intensity information condition) when pupils visit the Prevention Bus. The primary outcome will be weighted by the number of pupils who are eligible to take part in the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Health literacy is measured using five items of the HLS-EU Q47 questionnaire addressing prevention and immunization treatment (educational class condition, low intensity information condition) but before pupils visit the bus while they are still in their class room. 2. Health knowledge is measured with six previously developed immunization knowledge items, which psychometric properties were tested in our pilot study after treatment (educational class condition, low intensity information condition) but before pupils visit the bus while they are still in their class room. | — |
Countries
Germany
Contacts
Public ContactJoachim Seybold
Outcome results
None listed